Financials
Income statement
| Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
|---|---|---|---|---|
| Total reported revenue | 2.2B | 2.2B | 2.1B | 2.0B |
| Cost of revenue | 539M | 530M | 511M | 489M |
| Gross profit | 1.7B | 1.6B | 1.6B | 1.5B |
| Operating expense | ||||
| Research & development | 674M | 647M | 649M | 656M |
| Selling general and admin | 839M | 818M | 814M | 781M |
| Other operating expenses | — | — | — | — |
| Operating income | 159M | 165M | 111M | 64M |
| Non operating interest income | ||||
| Income | 83M | 86M | 88M | 93M |
| Expense | 28M | 29M | 28M | 29M |
| Other income expense | -94M | 5M | -3M | -5M |
| Pretax income | 120M | 227M | 168M | 123M |
| Tax provision | 26M | 34M | 36M | 16M |
| Net income | 94M | 193M | 132M | 107M |
| Basic EPS | — | 0.7 | 0.5 | 0.4 |
| Diluted EPS | — | 0.7 | 0.5 | 0.4 |
| Basic average shares | — | 13.7M | 13.7M | 13.7M |
| Diluted average shares | — | 13.9M | 13.8M | 14.0M |
| EBITDA | 239M | 337M | 275M | 227M |
| Net income from continuing op. | 94M | 193M | 132M | 107M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |